期刊
MOLECULAR CANCER RESEARCH
卷 16, 期 7, 页码 1112-1124出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-17-0601
关键词
-
资金
- Spanish Government
- FEDER [BIO2014-52566-R, BIO2017-85364-R, MDM-2014-0370]
- AGAUR [SGR2014-1121, SGR2017-1020]
- FPI from the Spanish Government [BES-2012-052683]
- Brigham Young University
- Simmons Center for Cancer Research at Brigham Young University
A major challenge in cancer research is to determine the biological and clinical significance of somatic mutations in noncoding regions. This has been studied in terms of recurrence, functional impact, and association to individual regulatory sites, but the combinatorial contribution of mutations to common RNA regulatory motifs has not been explored. Therefore, we developed a new method, MIRA (mutation identification for RNA alterations), to perform an unbiased and comprehensive study of significantly mutated regions (SMR) affecting binding sites for RNA-binding proteins (RBP) in cancer. Extracting signals related to RNA-related selection processes and using RNA sequencing (RNA-seq) data from the same specimens, we identified alterations in RNA expression and splicing linked to mutations on RBP binding sites. We found SRSF10 and MBNL1 motifs in introns, HNRPLL motifs at 5 0 UTRs, as well as 5 0 and 3 0 splice-site motifs, among others, with specific mutational patterns that disrupt the motif and impact RNA processing. MIRA facilitates the integrative analysis of multiple genome sites that operate collectively through common RBPs and aids in the interpretation of noncoding variants in cancer. MIRA is available at https://github.com/comprna/mira. Implications: The study of recurrent cancer mutations on potential RBP binding sites reveals new alterations in introns, untranslated regions, and long noncoding RNAs that impact RNA processing and provide a new layer of insight that can aid in the interpretation of noncoding variants in cancer genomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据